Our present approaches provided unequivocal evidence for critical suppressor roles of the GLP2 in the tumorigenesis of osteosarcoma and osteogenesis, and they supported the notion that GLP2 may be an alternative bona fide inhibiting factor of osteosarcoma and promoting factor of osteogenesis. Here, GCG is linked to osteosarcoma.